An Anti-HIV Drug Is Highly Effective Against SARS-CoV-2 In Vitro and Has Potential Benefit for Long COVID Treatment
Viruses · 2025
DOI: 10.3390/v17091170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Saken Khaidarov und 20 weiteren Autor:innen. Beteiligte Einrichtung: Biology Faculty Building, Department of Biology and Biotechnology, Al-Farabi Kazakh National University, Al-Farabi Street 71, Almaty 050040, Kazakhst…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Drug Treatment, Tenofovir, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The persistent evolution of SARS-CoV-2 necessitates novel antiviral strategies. This study evaluated the anti-HIV prodrugs tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) for repurposing against SARS-CoV-2, assessing key pharmacological indices (CC50, EC50, cytostatic effect, and therapeutic window). In vitro screening in Vero E6 cells measured cytotoxicity (via CCK-8/MTT assays) and antiviral activity against Kazakh B.1 and Wuhan strains. TDF (50 µg/mL) reduced high viral loads (MOI 2) by ~2 log10 (100% inhibition), with minimal cytotoxicity (≥75% viability). TAF achieved near-complete suppression (100% inhibition) at 50 µg/mL, exhibiting dose-dependent inhibition (68–100%) at lower viral loads (MOI 0.01). Both prodrugs showed enhanced antiviral activity with prolonged exposure (96 h). Synergy assessments demonstrated favourable combination indices (CI < 1). Electron microscopy confirmed virion integrity post-treatment. These findings highlight TDF and TAF as promising candidates against SARS-CoV-2, with particular potential for targeting lymphoid reservoirs—sites implicated in persistent viral reservoirs that may contribute to long COVID pathogenesis. Further clinical validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Faculty Building, Department of Biology and Biotechnology, Al-Farabi Kazakh National University, Al-Farabi Street 71, Almaty 050040, Kazakhstan.
- Department of Molecular Biology and Medical Genetics, Kazakh National Medical University Named After S.D. Asfendiyarov, Zheltoksan 37A Street, Almaty 050012, Kazakhstan.
- Department of Biology, Faculty of Education, Helmand University, Lashkar Gah 3901, Afghanistan.
- School of General Medicine 1, Kazakh National Medical University Named After S.D. Asfendiyarov, Tole-bi Street 94, No. 4 Academic Building, Room 206, Almaty 050012, Kazakhstan.
- Department of Propaedeutics of Internal Medicine, Kazakh National Medical University Named After S.D. Asfendiyarov, Tole-bi Street 94, Almaty 050012, Kazakhstan.
- Department of Pharmacology, Kazakh National Medical University Named After S.D. Asfendiyarov, Tole-bi Street 94, Almaty 050012, Kazakhstan.
ORCID-Profile: Saken Khaidarov, Abdul Bari Hejran, Bayan Nurgaliyeva, Aizhan Beisenova, Elmira Satbayeva, Askar Aidarov, Saniya Ossikbayeva, Jandos Amankulov, Banu Yeszhan, Edan Tulman, Nurlan Kozhabergenov, Yerbol Burashev
Zitieren
APA
Khaidarov, S., Hejran, A. B., Moldakaryzova, A., Izmailova, S., Nurgaliyeva, B., Beisenova, A., Mustafaeva, A., Nurzhanova, K., Belova, Y., Satbayeva, E., Aidarov, A., Ossikbayeva, S., Kukubassov, Y., Amankulov, J., Goncharova, T., Yeszhan, B., Tulman, E., Tazhibayeva, K. N., Sadykova, A., …, & Burashev, Y. (2025). An Anti-HIV Drug Is Highly Effective Against SARS-CoV-2 In Vitro and Has Potential Benefit for Long COVID Treatment. Viruses. https://doi.org/10.3390/v17091170
Vancouver
Khaidarov S, Hejran AB, Moldakaryzova A, Izmailova S, Nurgaliyeva B, Beisenova A, et al. An Anti-HIV Drug Is Highly Effective Against SARS-CoV-2 In Vitro and Has Potential Benefit for Long COVID Treatment. Viruses. 2025. doi:10.3390/v17091170
BibTeX
@article{Khaidarov2025,
author = {Khaidarov, Saken and Hejran, Abdul Bari and Moldakaryzova, Aizhan and Izmailova, Slu and Nurgaliyeva, Bayan and Beisenova, Aizhan and Mustafaeva, Aigul and Nurzhanova, Kuanysh and Belova, Yelena and Satbayeva, Elmira and Aidarov, Askar and Ossikbayeva, Saniya and Kukubassov, Yerlan and Amankulov, Jandos and Goncharova, Tatyana and Yeszhan, Banu and Tulman, Edan and Tazhibayeva, Karlygash N and Sadykova, Assel and Kozhabergenov, Nurlan and Burashev, Yerbol},
title = {An Anti-HIV Drug Is Highly Effective Against SARS-CoV-2 In Vitro and Has Potential Benefit for Long COVID Treatment},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17091170}
}
EUVIMED